Annales françaises d'anesthèsie et de rèanimation
-
Ann Fr Anesth Reanim · Jan 2010
Case Reports[Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
Massive bleeding is a dreaded complication of biventricular mechanical assistance implantation. Its origin is multifactorial. Blood products transfusion associated with correction of coagulopathy are sometimes insufficient. ⋯ After surgical haemostasis failure and despite the correction of coagulation disorders, a major bleeding persisted, so these patients received a single injection of 90 microg/kg of rFVIIa. This allowed in both cases a significant reduction of the bleeding and the restoration of normal haemodynamic conditions. This treatment was not complicated by any thrombotic accident.
-
Ann Fr Anesth Reanim · Jan 2010
Review Case Reports[Epidural analgesia and cutaneous angioma: need to perform MRI].
Epidural analgesia during labour is a well-accepted technique. Anaesthetists have to measure the risks of this technique during the first consultation with parturient. Complications, such as temporary or permanent neurological injuries due to this anaesthetic technique, are uncommon. ⋯ The likelihood of finding a spinal angioma with MRI is low and the modus operandi is infrequently modified. We report here a case of parturient with a cutaneous median angioma in the lumbar region, which was detected by MRI. An epidural analgesia was used for pain management during her labour.
-
Ann Fr Anesth Reanim · Jan 2010
Meta Analysis[Ondansetron: a meta-analysis on its efficacy to prevent postoperative nausea and vomiting after craniotomy in adults and children].
To justify the use of ondansetron as a preventive treatment for postoperative nausea and vomiting (PONV) of adults and children in neurosurgery. ⋯ Peroperative intravenous dose of ondansetron 4 mg in neurosurgery in adults is required to prevent PONV during the first postoperative 24 hours. However, further studies are needed to determine best time and dose infusion to prolong clinical efficacy.